REMEDIA studied the contribution of the exposome to chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF).

ATHLETE measured multiple environmental exposures during pregnancy, childhood, and adolescence and linked them to children’s biological responses and cardiometabolic, respiratory, and mental health.

HEDIMED identified exposomic determinants behind the rapid increase of immune-mediated diseases (IMDs) such as type 1 diabetes, celiac disease, allergies and asthma.

LongITools studied interactions between the environment, lifestyle and health in determining the risk of developing chronic cardiovascular and metabolic diseases.

EPHOR studied the working-life exposome and aims to reduce the burden of Non-Communicable Diseases (NCDs) on EU healthcare systems, and improve EU workforce productivity and industry competitiveness.

Equal-Life developed and tested combined exposure data using a novel approach to multi-modal exposures and their impact on children’s mental health and development.

EXIMIOUS mapped exposome, immune system (immunome), other omics, and clinical and socioeconomic data to identify "immune fingerprints’ that are early signs of poor health and predictors of disease.

EXPANSE aimed to decrease unexplained CardioMetabolic and Pulmonary Disease (CMPD) risk in urban populations and to gain insights into mediating biological mechanisms and causality.

HEAP implemented proof-of-concept projects for integrating data from wearable sensors, consumer purchases and environmental monitoring into exposomic research.